Newsroom

Default Image

Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead...

Oragenics Inc. (NYSE American: OGEN), a biotechnology firm specializing in intranasal therapeutics for brain-related conditions, has announced a manufacturing agreement...

Jul 16, 2025 Press Release
Default Image

Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead...

Oragenics Inc. (NYSE American: OGEN), a biotechnology firm specializing in intranasal therapeutics for brain-related conditions, has announced a manufacturing agreement...

Jul 16, 2025 Press Release
Default Image

TBC Uzbekistan Named Among Global Fintech Leaders by CNBC and...

TBC Uzbekistan has been acknowledged as one of the world’s leading fintech companies in the neobanking category by CNBC and...

Jul 16, 2025 Press Release
Default Image

TBC Uzbekistan Named Among Global Fintech Leaders by CNBC and...

TBC Uzbekistan has been acknowledged as one of the world’s leading fintech companies in the neobanking category by CNBC and...

Jul 16, 2025 Press Release
Default Image

TBC Uzbekistan Named Among Global Fintech Leaders by CNBC and...

TBC Uzbekistan has been acknowledged as one of the world’s leading fintech companies in the neobanking category by CNBC and...

Jul 16, 2025 Press Release
Default Image

Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that the herpes...

Jul 16, 2025 Press Release
Default Image

Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that the herpes...

Jul 16, 2025 Press Release
Default Image

Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that the herpes...

Jul 16, 2025 Press Release
Default Image

NanoViricides, Inc. Advances MPox Treatment Amid WHO’s Extended Global Health...

NanoViricides, Inc. (NYSE American: NNVC), a leader in the development of host-mimetic nanomedicine, has reaffirmed its commitment to combating the...

Jul 16, 2025 Press Release